V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003455 | 10002195 | 1.72 | 75 | Curative (C) | 2018-06-29 | 2018-07-19 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 10479078 | CHLORAMBUCIL |
| 10003456 | 10002196 | 1.63 | 87.4 | Adjuvant (A) | 2016-07-30 | 2016-08-08 | Abiraterone | 02 | Y | 10479135 | CAPECITABINE + GEMCITABINE |
| 10003457 | 10002197 | 1.5 | 83.1 | null | 2015-05-30 | 2015-05-31 | FLUOROURACIL | 02 | Y | 10479231 | FLUOROURACIL |
| 10003458 | 10002198 | 1.66 | 88.4 | Palliative (P) | 2016-12-13 | 2017-01-10 | Gemcitabine + Capecitabine | N | N | 10479253 | CTD |
| 10003459 | 10002198 | 1.78 | 75.2 | Not known (9) | 2016-07-17 | 2016-07-25 | Abiraterone | N | N | 10479253 | PACLITAXEL |
| 10003460 | 10002198 | 0 | 0 | Palliative (P) | null | 2017-10-01 | Irinotecan + Modified De Gramont | N | N | 10479253 | IRINOTECAN + MDG |
| 10003461 | 10002199 | 1.7 | null | Neo-adjuvant (N) | 2017-12-07 | 2017-12-30 | FEC + DOCETAXEL | N | N | 10479279 | FEC + DOCETAXEL |
| 10003462 | 10002200 | 1.8 | 89 | Adjuvant (A) | 2018-07-02 | 2018-07-04 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | N | 10479292 | CHLORAMBUCIL |
| 10003463 | 10002200 | 1.66 | 55 | Curative (C) | 2017-09-30 | 2017-10-13 | Capecitabine 35days + RT | 2 | N | 10479292 | CAPECITABINE + RT |
| 10003464 | 10002200 | 1.66 | 87.5 | Palliative (P) | 2018-07-31 | 2018-07-31 | ABVD | N | N | 10479292 | CISPLATIN + ETOPOSIDE |
| 10003465 | 10008803 | 1.8 | 120 | Disease modification (D) | 2018-02-27 | 2018-02-28 | BCG Intravesical | N | N | 10479334 | BCG |
| 10003466 | 10002201 | 1.73 | null | null | null | 2018-11-19 | BCG Intravesical | N | null | 10479416 | CAPECITABINE + CISPLATIN |
| 10003467 | 10002201 | null | null | Curative (C) | 2016-06-27 | 2016-07-11 | Cisplatin + Radiotherapy | N | Y | 10479416 | CISPLATIN + RT |
| 10003468 | 10002201 | 1.67 | 77.1 | Adjuvant (A) | 2015-05-30 | 2015-06-20 | Fluorouracil+Mitomycin+RT (Bladder) | N | Y | 10479416 | EC |
| 10003469 | 10002201 | null | 87.599 | Curative (C) | 2014-04-19 | 2014-04-20 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | null | 10479416 | ABIRATERONE |
| 10003470 | 10002202 | 1.8 | 81 | Adjuvant (A) | 2016-09-15 | 2016-10-13 | CHOP - 21 days | 02 | N | 10479577 | FLUOROURACIL + MITOMYCIN + RT |
| 10003471 | 10002203 | 1.68 | 69.5 | Palliative (P) | 2017-03-03 | 2017-03-05 | Temozolomide + RT | 2 | Y | 10479591 | EC |
| 10003472 | 10002203 | 1.71 | 111 | Curative (C) | 2016-11-10 | 2016-12-08 | Capecitabine 35days + RT | N | Y | 10479591 | CAPECITABINE + RT |
| 10003473 | 10002204 | 1.71 | null | Neo-adjuvant (N) | 2017-11-30 | 2017-11-30 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10479742 | ABIRATERONE |
| 10003474 | 10006435 | 1.61 | null | Curative (C) | 2014-12-07 | 2014-12-10 | Cisplatin + Radiotherapy | 02 | Y | 10479749 | CISPLATIN + RT |
| 10003475 | 10002205 | 1.8 | 69 | Adjuvant (A) | 2015-01-03 | 2015-01-03 | PACLITAXEL | N | N | 10479787 | CISPLATIN |
| 10003476 | 10002206 | 1.7 | null | Neo-adjuvant (N) | 2014-07-31 | 2014-08-26 | Bortezomib +/- Dexamethasone | N | N | 10479804 | ABVD |
| 10003477 | 10002207 | 1.71 | 82.1 | Palliative (P) | null | 2014-10-17 | Fluorouracil + Folinic Acid Weekly | N | N | 10479858 | FLUOROURACIL |
| 10003478 | 10002208 | null | 76.8 | Palliative (P) | 2017-03-09 | 2017-03-09 | BCG Intravesical | N | N | 10479899 | CTD |
| 10003479 | 10002209 | 1.74 | 57 | Adjuvant (A) | 2018-10-02 | 2018-10-29 | FLUOROURACIL | N | N | 10479928 | FLUOROURACIL |
| 10003480 | 10002209 | 1.75 | 93.6 | Adjuvant (A) | 2018-02-04 | 2018-02-04 | FLUOROURACIL | 02 | N | 10479928 | FLUOROURACIL |
| 10003481 | 10002209 | 1.65 | 60 | Curative (C) | 2018-12-20 | 2019-01-10 | EC | 02 | Y | 10479928 | CAPECITABINE + GEMCITABINE |
| 10003482 | 10002209 | 1.55 | 64.1 | Adjuvant (A) | 2017-09-30 | 2017-10-02 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 10479928 | FLUOROURACIL |
| 10003483 | 10002210 | 1.69 | null | Curative (C) | 2017-03-09 | 2017-03-15 | Cisplatin + Radiotherapy | N | N | 10480034 | CISPLATIN + RT |
| 10003484 | 10002211 | null | 70.8 | Palliative (P) | 2017-04-21 | 2017-04-21 | EC | N | null | 10480068 | EC |
| 10003485 | 10002212 | 1.78 | 91 | Adjuvant (A) | 2018-01-17 | 2018-01-24 | EC | N | N | 10480070 | CISPLATIN + ETOPOSIDE |
| 10003486 | 10002213 | 1.75 | 111.2 | Palliative (P) | 2017-01-10 | 2017-08-21 | Capecitabine + Cisplatin | N | N | 10480081 | BCG |
| 10003487 | 10002214 | 1.6 | 77.4 | Neo-adjuvant (N) | 2017-01-27 | 2017-03-09 | BCG Intravesical | 02 | N | 10480101 | ABIRATERONE |
| 10003488 | 10002215 | 1.77 | 74.25 | Disease modification (D) | 2016-12-22 | 2016-12-30 | Bortezomib +/- Dexamethasone | 2 | N | 10480109 | TEMOZOLOMIDE + RT |
| 10003489 | 10002216 | 1.72 | 92 | Curative (C) | 2017-01-16 | 2017-01-16 | IMATINIB | 02 | N | 10480123 | CISPLATIN |
| 10003490 | 10006437 | 1.77 | 71 | null | 2018-01-06 | 2018-01-17 | Azacitidine | N | N | 10480145 | AZACITIDINE |
| 10003491 | 10008096 | 1.5 | 54.8 | Adjuvant (A) | 2017-06-28 | 2017-07-01 | Capecitabine + Cisplatin | 2 | N | 10480170 | CHOP |
| 10003492 | 10002217 | 1.57 | 0 | Adjuvant (A) | 2014-10-27 | 2014-10-27 | ABVD | 02 | Y | 10480174 | BCG |
| 10003493 | 10002218 | 0 | 68.8 | Curative (C) | 2018-12-08 | 2018-12-08 | BCG Intravesical | N | N | 10480194 | TEMOZOLOMIDE + RT |
| 10003494 | 10002219 | 1.9 | 75.1 | Curative (C) | 2017-10-15 | 2017-10-15 | Gemcitabine + Capecitabine | 02 | N | 10480205 | PACLITAXEL |
| 10003495 | 10002220 | 1.71 | null | Adjuvant (A) | 2009-11-21 | 2017-10-11 | CTD | 2 | N | 10480234 | ABIRATERONE |
| 10003496 | 10006438 | 1.77 | null | Adjuvant (A) | 2014-05-31 | 2014-06-05 | Cisplatin + Etoposide (3 day) | 02 | null | 10480250 | CVD |
| 10003497 | 10006438 | 1.69 | 75 | Disease modification (D) | 2016-09-22 | 2016-09-22 | ABVD | 2 | N | 10480250 | CTD |
| 10003498 | 10006438 | null | 60 | Adjuvant (A) | 2017-03-28 | 2017-04-06 | Abiraterone | N | Y | 10480250 | AZACITIDINE |
| 10003499 | 10002221 | 1.69 | 68.3 | Adjuvant (A) | 2017-11-09 | 2017-11-24 | Temozolomide + RT | 02 | N | 10480343 | EC |
| 10003500 | 10002222 | null | null | Palliative (P) | 2017-07-04 | 2017-07-09 | Irinotecan + Modified De Gramont | N | N | 10480361 | IRINOTECAN + MDG |
| 10003501 | 10002222 | 1.7 | 96.2 | Neo-adjuvant (N) | 2018-02-28 | 2018-03-09 | CAPECITABINE + RT | 02 | N | 10480361 | CAPECITABINE + RT |
| 10003502 | 10002223 | 1.65 | 67.2 | Adjuvant (A) | 2017-08-15 | 2017-08-30 | Cisplatin | N | N | 10480428 | CVD |
| 10003503 | 10002224 | 1.6 | 101 | Palliative (P) | 2016-10-01 | 2016-10-09 | CTD | N | N | 10480547 | BORTEZOMIB |
| 10003504 | 10002225 | 1.75 | 87.4 | Neo-adjuvant (N) | 2015-08-29 | 2015-09-14 | Chlorambucil | 02 | N | 10480567 | CAPECITABINE + CISPLATIN |